Home
       
  HOME  


Back

Corporate Information
  • Company Presentation
  • Business Segments
  • Strategy & Goals
  • President’s Message
  • Year in Brief
  • Management
  • Subsidiaries
  • Acquisitions & Divestments
  • Addresses
    News & Reports
  • Reports
  • Presentations
  • Press releases
    Financial Information
  • Financial Summary
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Illustrations
    Shareholder Information
  • Shareholders
  • Shares & Dividends
  • Annual General Meeting
  • Financial Calendar
     
       

    Össur hf.

    http://www.ossur.com
    Össur hf.
    Grjothals 5
    110 Reykjavik
    ICELAND
    Tel.: ‎+ 354 515 1300
    Fax: ‎+ 354 515 1366
    E-mail: mail@ossur.com

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer
    Year in Brief  

    year 2015

    Highlights 2015

    • Sales growth was 5% measured in local currency and sales amounted to USD 483 million.

    • Bracing and supports sales growth was 5% and 5% organic, both measured in local currency.

    • Prosthetics sales growth was 6% and 4% organic, both measured in local currency.

    • Gross profit amounted to USD 303 million or 63% of sales, compared to USD 323 million or 63% of sales in 2014.

    • EBITDA amounted to USD 97 million or 20% of sales. Adjusted EBITDA amounted to USD 99 million or 20% of sales compared to USD 104 million or 20% of sales in 2014.

    • Net profit amounted to USD 51 million or 11% of sales compared to USD 59 million or 12% of sales in 2014.

    • USD strengthening has had a significant negative impact on reported sales and profits when comparing to prior year results.

    • Cash generated by operations amounted to USD 84 million or 17% of sales compared to USD 98 million or 19% of sales in 2014.

    • The Board of Directors will propose to the Annual General Meeting in 2016 that the Company pays a cash dividend of DKK 0.12 per share for 2015, equivalent to 16% of net earnings in 2015.

    • The Board of Directors will also propose to the Annual General Meeting to reduce the share capital by cancelling 1,892,688 of the Company's own shares.






     
    Back
     
     
       Privacy Policy | Disclaimer | Recommend this site to a friend | © Euroland.com 2000-2020